Targeting the adrenomedullin-2 receptor for the discovery and development of novel anti-cancer agents.
Ameera B A JailaniKamilla J A BigosParis AvgoustouJoseph L EganRobert A HathwayTimothy Michael SkerryGareth Owain RichardsPublished in: Expert opinion on drug discovery (2022)
R antagonists support the promise of this class of compounds as potential anti-cancer therapeutics.